Purchase Order 75N93021P00918

This is a $5,820 firm-fixed price purchase order awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for monoclonal antibody production services. The contract is not set-aside and was awarded under the NIH's Acquisition Operations. Precision Antibody is a for-profit manufacturer of specialized biological materials and services, including custom antibody development, cell lines, and peptide synthesis, in support of biomedical...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $132,862.50 firm fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to support the agency's research efforts. Under the contract, TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ, Precision Antibody will provide monoclonal cell...

This is a firm fixed-price purchase order awarded by the U.S. Department of Agriculture (USDA) Agricultural Research Service (ARS) Midwest Area to Envigo Bioproducts Inc. for $22,655.00. The contract is for hybridoma services across three stages: Stage 1 - hybridoma services for 3 immunogens and 10 Balb/C mice; Stage 2 - fusion and subcloning services (option); and Stage 3 - cloning and small-scale antibody production (option). The contract has an ultimate completion date of May 31, 2025. Envigo...

This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for the delivery of custom rabbit monoclonal antibodies to support the development of diagnostic tests for taeniasis and cysticercosis. The award, valued at $49,981.00, was made by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia and has a period of performance from September 30, 2024 to April 22, 2025. The original solicitation, a Request for Quotations (RFQ), was...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $210,338.00 firm fixed-price purchase order to Creative Biolabs Inc. for mouse antibody production services across Phases I through IV. The contract, which runs through September 22, 2025, does not have a set-aside designation. Creative Biolabs, a specialized biotechnology and pharmaceutical services provider, will deliver custom solutions in...

This firm-fixed price purchase order was awarded to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,951.40 award is for the delivery of custom antibody development services including monoclonal antibodies, cell lines, labeled antibodies, polyclonal antibodies, and peptide synthesis. These...

This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody). The contract is for the preparation of monoclonal antibodies against the MARCH1 protein, with a ceiling value of $16,900.00 and a performance period through July 31, 2025. A&G Pharmaceutical is a for-profit manufacturer of biological...

Genscript USA Inc. has been awarded a $24,705 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide services for creating customized monoclonal antibodies and plasmids in support of the agency's biomedical research efforts. As the prime contractor, Genscript will leverage its expertise in gene synthesis and monoclonal antibody development to deliver the requested biological products and services. This contract...

This is a $13,062.24 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for Genscript to provide monoclonal antibody (MOAB) development services, with a final completion date of September 9, 2025. This appears to be a definitive contract and does not have a set-aside designation. Genscript is a well-established federal contractor, having received numerous awards from agencies like...

This firm-fixed price purchase order was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to A&G Pharmaceutical, Inc., doing business as Precision Antibody. The $9,750 contract is for the delivery of monoclonal antibodies. Precision Antibody is a for-profit manufacturer of goods that specializes in custom antibody development services to support biomedical research. The company has an extensive history of...